Agios Pharmaceuticals | Ativos



Assets Alterar Data
AbbVie USD 136.17B 1B 2025-03
Agios Pharmaceuticals USD 1.56B 107.68M 2025-03
Alnylam Pharmaceuticals USD 4.57B 352.21M 2025-06
Amgen USD 89.37B 2.47B 2025-03
Arrowhead Research USD 1.57B 559.8M 2025-03
Astellas Pharma JPY 3.34T 3.71B 2025-06
AstraZeneca USD 112.42B 6.17B 2025-06
Bayer EUR 109.18B 1.67B 2025-03
Biogen USD 28.33B 297.1M 2025-06
BioMarin Pharmaceutical USD 7.15B 158.07M 2025-03
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Daiichi Sankyo JPY 3.46T 3.5B 2025-06
Eli Lilly USD 89.39B 10.67B 2025-03
Exelixis USD 2.68B 159.17M 2025-07
Gilead Sciences USD 56.43B 2.56B 2025-03
GlaxoSmithKline GBP 59.26B 1.45B 2025-06
Incyte USD 5.82B 71.99M 2025-06
Ionis Pharmaceuticals USD 2.99B 172.18M 2025-06
Merck USD 115.12B 1.98B 2025-03
Moderna USD 12.7B 1.44B 2025-03
Novartis USD 104.4B 4.45B 2025-06
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 208.03B 5.37B 2025-03
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Sarepta Therapeutics USD 3.47B 497.79M 2025-03
Vertex Pharmaceuticals USD 22.53B 293M 2024-12


Agios Pharmaceuticals Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.